Xiang Pan

Xiang Pan is the current Associate Director and Principal Scientist at Clade Therapeutics, focusing on hiPSC Engineering for allogenic cell therapy. Prior to this role, Xiang Pan worked as a Senior Scientist at Goldfinch Bio, where they led the Human Biology Platform and optimized hiPSC derived podocyte differentiation protocol. Xiang Pan also worked as a Senior Associate Scientist at Cue Biopharma, focusing on CHO cell expression and purification for Immuno-STATs. With a background in Biochemistry and Molecular Biology, Xiang Pan has a strong research history and expertise in developing innovative protocols for in-vitro compound screening.